Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8749313 | Microbial Pathogenesis | 2018 | 7 Pages |
Abstract
These PUVA-treated bacteria, with metabolic activity and proliferation inability, seem to be good enough to be tested in vitro and in vivo as a candidate for vaccine against UTI. Therefore it seems the first step toward development of a vaccine candidate is successfully done. The immunogenicity and protectivity of these treated bacteria is under evaluation.
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
Zahra Jalili, Moein Saleh, Saeid Bouzari, Mohammad Pooya,